Glycine-β-muricholic Acid
| Catalog Number | BL-M000530 |
| CAS Number | 66225-78-3 |
| Description | Glycine-β-muricholic acid (GβMCA) is a potent, oral bioactive and intestine-selective antagonist of the farnesoid X receptor (FXR) that may be a candidate for the treatment of metabolic disorders. |
 | |
| IUPAC Name | 2-[[(4R)-4-[(3R,5R,6S,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid |
| Synonyms | Gly-MCA; GβMCA; N-[(3α,5β,6β,7β)-3,6,7-trihydroxy-24-oxocholan-24-yl]-glycine; 5β-Cholanic acid-3α,6β,7β-triol N-(carboxymethyl)-amide |
| Molecular Weight | 465.63 |
| Molecular Formula | C26H43NO6 |
| Boiling Point | 673.4±55.0 °C at 760 mmHg |
| Purity | ≥95% |
| Density | 1.213±0.06 g/cm3 |
| Appearance | Crystalline Solid |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 67.07%, H 9.31%, N 3.01%, O 20.62% |
| Canonical SMILES | CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(C(C4C3(CCC(C4)O)C)O)O)C |
| InChI | InChI=1S/C26H43NO6/c1-14(4-7-20(29)27-13-21(30)31)16-5-6-17-22-18(9-11-25(16,17)2)26(3)10-8-15(28)12-19(26)23(32)24(22)33/h14-19,22-24,28,32-33H,4-13H2,1-3H3,(H,27,29)(H,30,31)/t14-,15-,16-,17+,18+,19+,22+,23+,24-,25-,26-/m1/s1 |
| InChI Key | ZQYUKJFJPJDMMR-IIWZPVADSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
